Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 2023 14 Ιούλιος 2023NewsVeterinaryMedicines EMA statement on ongoing review of GLP-1 receptor agonists 11 Ιούλιος 2023NewsHuman Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 7 Ιούλιος 2023NewsHumanPharmacovigilanceReferrals Phasing out of extraordinary COVID-19 regulatory flexibilities 6 Ιούλιος 2023NewsHumanCOVID-19 Global regulators confirm good safety profile of COVID-19 vaccines 5 Ιούλιος 2023NewsHumanCOVID-19Medicines Use of real-world evidence in regulatory decision making – EMA publishes review of its studies 23 Ιούνιος 2023NewsHumanData on medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023 23 Ιούνιος 2023NewsHumanMedicines ACT EU: creating a better environment for clinical trials through collaboration 22 Ιούνιος 2023NewsHumanClinical trials Report: How EU ensured safety of medicines during COVID-19 22 Ιούνιος 2023NewsHumanPharmacovigilance Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 2023 16 Ιούνιος 2023NewsVeterinaryMaximum residue limitMedicines 1 … 29 30 31 32 33 Page 33 of 384 34 35 36 37 … 384
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 2023 14 Ιούλιος 2023NewsVeterinaryMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 7 Ιούλιος 2023NewsHumanPharmacovigilanceReferrals
Global regulators confirm good safety profile of COVID-19 vaccines 5 Ιούλιος 2023NewsHumanCOVID-19Medicines
Use of real-world evidence in regulatory decision making – EMA publishes review of its studies 23 Ιούνιος 2023NewsHumanData on medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023 23 Ιούνιος 2023NewsHumanMedicines
ACT EU: creating a better environment for clinical trials through collaboration 22 Ιούνιος 2023NewsHumanClinical trials
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 2023 16 Ιούνιος 2023NewsVeterinaryMaximum residue limitMedicines